HuGE Literature Finder
Records
1
-
19
| JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome. Journal of cancer research and clinical oncology 2022 Oct . Kandu?a Zuzanna, Janowski Micha?, Wi?ckowska Barbara, Paczkowska Edyta, Lewandowski Krzyszt |
| [Analysis of the effect of gene mutations on the efficacy of ruxolitinib in patients with myelofibrosis based on second-generation sequencing technology]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2022 6 43 (4): 323-329. Tan Y X, Luo J, Huang J X, Luo D M, Liang H Y, Zhou X, Liu X L, Xu |
| Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing Era. Journal of clinical medicine 2021 Mar 10 (5): . Lee Jong-Mi, Lee Howon, Eom Ki-Seong, Lee Sung-Eun, Kim Myungshin, Kim Yongg |
| Clinical features and outcomes of JAK2 V617F-positive polycythemia vera and essential thrombocythemia according to the JAK2 V617F allele burden. Blood research 2021 11 56 (4): 259-265. Lee A-Jin, Kim Sang-Gyung, Nam Jun Yeb, Yun Jaehum, Ryoo Hun-Mo, Bae Sung H |
| JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis. Blood cancer journal 2021 12 11 (12): 199. Guglielmelli Paola, Loscocco Giuseppe G, Mannarelli Carmela, Rossi Elena, Mannelli Francesco, Ramundo Francesco, Coltro Giacomo, Betti Silvia, Maccari Chiara, Ceglie Sara, Chiusolo Patrizia, Paoli Chiara, Barbui Tiziano, Tefferi Ayalew, De Stefano Valerio, Vannucchi Alessandro |
| Targeted molecular characterization shows differences between primary and secondary myelofibrosis. Genes, chromosomes & cancer 2019 7 59 (1): 30-39. Courtier Frédéric, Garnier Séverine, Carbuccia Nadine, Guille Arnaud, Adélaide José, Chaffanet Max, Hirsch Pierre, Paz Damien Luque, Slama Bohrane, Vey Norbert, Ugo Valérie, Delhommeau François, Rey Jérome, Birnbaum Daniel, Murati An |
| Genetic variation in IL28B (IFNL3) and response to interferon-alpha treatment in myeloproliferative neoplasms. European journal of haematology 2018 Jan . Lindgren Marie, Samuelsson Jan, Nilsson Lars, Knutsen Håvar, Ghanima Waleed, Westin Johan, Johansson Peter L, Andréasson Bjö |
| TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms. Turkish journal of haematology : official journal of Turkish Society of Haematology 2017 Feb . Soyer Nur, Tezcanl? Kaymaz Burçin, Cömert Özkan Melda, Aktan Ça?da?, Küçükaslan Ali ?ahin, ?ahin Fahri, Kosova Buket, Saydam Gür |
| Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients. Blood cancer journal 2017 12 7 (12): 662. Cerquozzi S, Barraco D, Lasho T, Finke C, Hanson C A, Ketterling R P, Pardanani A, Gangat N, Tefferi |
| Genetic Characteristics of Polycythemia Vera and Essential Thrombocythemia in Korean Patients. Journal of clinical laboratory analysis 2016 May . Yoo Eun-Hyung, Park Kyung-Jin, Won Hong-Hee, Park Jun-Hee, Park Jong-Ho, Lee Seung-Tae, Kim Hee-Jin, Bang Soo-Mee, Chi Hyun-Sook, Jung Chul Won, Kim Sun-Hee, Yun Hongseok, Sun Choong-Hyun, Park Inho, Lee Seungmook, Lee Clarence, Merriman Barry, Luo Raymond, Tan Eileen Hwee Hong, Park Keun-Joon, Yoo Na-Kyung, Kang Jason J, Kim Jong-W |
| Impact of JAK2V617F Mutation Burden on Disease Phenotype in Chinese Patients with JAK2V617F-positive Polycythemia Vera (PV) and Essential thrombocythemia (ET). International journal of medical sciences 2016 13 (1): 85-91. Zhao Shixiang, Zhang Xiang, Xu Yang, Feng Yufeng, Sheng Wenhong, Cen Jiannong, Wu Depei, Han Y |
| Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis. Turkish journal of haematology : official journal of Turkish Society of Haematology 2015 Apr . Yönal Ipek, Da?lar Aday Aynur, Akadam Teker Ba?ak, Ceylan Y?lmaz, Nalcac? Meliha, Yavuz Akif Selim, Sarg?n Fatma Den |
| Impact of JAK2 V617F mutation on hemogram variation in patients with non-reactive elevated platelet counts. PloS one 2013 8 (2): e57856. Zhou Juan, Ye Yuanxin, Zeng Shugen, Zhou Yi, Mao Zhigang, Song Xingbo, Ying Binwu, Lu Xiaojun, Jiang Hong, Wang Lanl |
| The JAK2V617F tyrosine kinase mutation has no impact on overall survival and the risk of leukemic transformation in myelofibrosis. Medical oncology (Northwood, London, England) 2012 Dec 29 (4): 2379-84. Helbig Grzegorz, Wieczorkiewicz Agata, Wo?niczka Krzysztof, Wi?niewska-Pi?ty Katarzyna, Rusek Anna, Kyrcz-Krzemie? S?awomi |
| Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases. Haematologica 2012 Dec 97 (12): 1890-4. Schnittger Susanne, Bacher Ulrike, Alpermann Tamara, Reiter Andreas, Ulke Madlen, Dicker Frank, Eder Christiane, Kohlmann Alexander, Grossmann Vera, Kowarsch Andreas, Kern Wolfgang, Haferlach Claudia, Haferlach Torst |
| A3669G polymorphism of glucocorticoid receptor is a susceptibility allele for primary myelofibrosis and contributes to phenotypic diversity and blast transformation. Blood 2012 Oct 120 (15): 3112-7. Poletto Valentina, Rosti Vittorio, Villani Laura, Catarsi Paolo, Carolei Adriana, Campanelli Rita, Massa Margherita, Martinetti Myriam, Viarengo Gianluca, Malovini Alberto, Migliaccio Anna Rita, Barosi Giovan |
| The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population. BMC medical genetics 2012 13 (1): 6. Ohyashiki Junko H, Yoneta Masayuki, Hisatomi Hisashi, Iwabuchi Tamiko, Umezu Tomohiro, Ohyashiki Kazu |
| A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. Leukemia 2010 Sep 24 (9): 1574-9. Passamonti F, Rumi E, Pietra D, Elena C, Boveri E, Arcaini L, Roncoroni E, Astori C, Merli M, Boggi S, Pascutto C, Lazzarino M, Cazzola |
| Proteomic study of the impact of the JAK2-V617F mutation on the phenotype of essential thrombocythemia. Experimental hematology 2008 Dec 36 (12): 1642-7. Mossuz Pascal, Arlotto Marie, Hermouet Sylvie, Bouamrani Ali, Lippert Eric, Girodon François, Dobo Irène, Vincent Praloran, Cahn Jean Yves, Berger Franço |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 30, 2023
- Content source: